Kyverna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	32.19	124.09	96.62	34.65	37.74	76.07
Short-Term Investments	204.25	155.16	189.36	22.9	13.59	-
Cash & Short-Term Investments	236.45	279.25	285.98	57.54	51.32	76.07
Cash Growth	-2.56%	-2.35%	396.98%	12.12%	-32.53%	-
Other Current Assets	5.28	3.7	4.62	3.12	1.93	1.02
Total Current Assets	241.73	282.95	290.6	60.66	53.25	77.09
Net Property, Plant & Equipment	9.73	5.42	10.66	10.61	12.44	7.81
Other Long-Term Assets	5.57	5.45	3.39	3.92	1.23	0.59
Total Assets	257.02	293.83	304.65	75.2	66.92	85.49
Accounts Payable	11.6	5.31	4.62	4.36	1.45	0.77
Accrued Expenses	16.09	27.21	25.19	12.58	8.23	8.34
Current Portion of Leases	1.99	3.97	3.94	2.92	2.28	0.81
Unearned Revenue	-	-	-	-	-	6
Total Current Liabilities	29.67	36.49	33.76	19.86	11.95	15.93
Long-Term Debt	24.81	24.74	-	-	-	-
Long-Term Leases	6.96	0.32	4.3	6.16	8.29	4.74
Other Long-Term Liabilities	-	-	-	-	0.01	2.35
Total Long-Term Liabilities	31.77	25.06	4.3	6.16	8.29	7.09
Total Liabilities	61.44	61.55	38.06	26.02	20.25	23.02
Common Stock	0	0	-	-	-	-
Additional Paid-in Capital	660.23	657.01	530	4.64	1.71	0.53
Accumulated Other Comprehensive Income	-0.1	0.1	0.11	0	-0.03	-
Retained Earnings	-464.56	-424.83	-263.52	-136.04	-75.68	-46.78
Total Common Shareholders' Equity	195.58	232.28	266.59	-131.4	-74	-46.25
Minority Interest	-	-	-	180.57	120.67	108.72
Shareholders' Equity	195.58	232.28	266.59	49.18	46.68	62.47
Total Liabilities & Equity	257.02	293.83	304.65	75.2	66.92	85.49
Total Debt	33.76	29.03	8.24	9.08	10.56	5.56
Net Cash (Debt)	202.69	250.22	277.74	48.46	40.76	70.51
Net Cash Growth	-19.00%	-9.91%	473.08%	18.91%	-42.20%	-
Net Cash Per Share	4.17	5.65	7.25	71.94	89.48	0.27
Book Value	195.58	232.28	266.59	-131.4	-74	-46.25
Book Value Per Share	4.03	5.25	6.95	-195.06	-162.46	-0.17
Tangible Book Value	195.58	232.28	266.59	-131.4	-74	-46.25
Tangible Book Value Per Share	4.03	5.25	6.95	-195.06	-162.46	-0.17

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q